India's Lupin Starts Strategic Review of Japanese Arm

Lupin Ltd. has started a strategic review of its Japanese operations, people with knowledge of the matter said, as the Indian pharmaceutical company seeks to focus on higher-growth areas.

The Mumbai-based drugmaker is working with advisers as it explores options for the Japan business, according to the people, who asked not to be identified because the information is private.